CanSino Biologics (Germany) Market Value

CJH Stock  EUR 3.40  0.04  1.16%   
CanSino Biologics' market value is the price at which a share of CanSino Biologics trades on a public exchange. It measures the collective expectations of CanSino Biologics investors about its performance. CanSino Biologics is trading at 3.40 as of the 10th of January 2025. This is a 1.16 percent decrease since the beginning of the trading day. The stock's lowest day price was 3.4.
With this module, you can estimate the performance of a buy and hold strategy of CanSino Biologics and determine expected loss or profit from investing in CanSino Biologics over a given investment horizon. Check out CanSino Biologics Correlation, CanSino Biologics Volatility and CanSino Biologics Alpha and Beta module to complement your research on CanSino Biologics.
Symbol

Please note, there is a significant difference between CanSino Biologics' value and its price as these two are different measures arrived at by different means. Investors typically determine if CanSino Biologics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CanSino Biologics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

CanSino Biologics 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to CanSino Biologics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of CanSino Biologics.
0.00
12/11/2024
No Change 0.00  0.0 
In 31 days
01/10/2025
0.00
If you would invest  0.00  in CanSino Biologics on December 11, 2024 and sell it all today you would earn a total of 0.00 from holding CanSino Biologics or generate 0.0% return on investment in CanSino Biologics over 30 days. CanSino Biologics is related to or competes with CSSC Offshore, Hochschild Mining, PENN NATL, DETALION GAMES, GigaMedia, and GAMESTOP. CanSino Biologics Inc. develops, manufactures, and commercializes vaccines in the Peoples Republic of China More

CanSino Biologics Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure CanSino Biologics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess CanSino Biologics upside and downside potential and time the market with a certain degree of confidence.

CanSino Biologics Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for CanSino Biologics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as CanSino Biologics' standard deviation. In reality, there are many statistical measures that can use CanSino Biologics historical prices to predict the future CanSino Biologics' volatility.
Hype
Prediction
LowEstimatedHigh
0.173.408.06
Details
Intrinsic
Valuation
LowRealHigh
0.142.897.55
Details
Naive
Forecast
LowNextHigh
0.063.087.74
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
3.383.734.07
Details

CanSino Biologics Backtested Returns

CanSino Biologics appears to be very risky, given 3 months investment horizon. CanSino Biologics secures Sharpe Ratio (or Efficiency) of 0.0728, which signifies that the company had a 0.0728% return per unit of risk over the last 3 months. We have found thirty technical indicators for CanSino Biologics, which you can use to evaluate the volatility of the firm. Please makes use of CanSino Biologics' Mean Deviation of 3.69, downside deviation of 5.3, and Risk Adjusted Performance of 0.0426 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, CanSino Biologics holds a performance score of 5. The firm shows a Beta (market volatility) of 0.45, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, CanSino Biologics' returns are expected to increase less than the market. However, during the bear market, the loss of holding CanSino Biologics is expected to be smaller as well. Please check CanSino Biologics' total risk alpha, treynor ratio, and the relationship between the jensen alpha and sortino ratio , to make a quick decision on whether CanSino Biologics' price patterns will revert.

Auto-correlation

    
  0.43  

Average predictability

CanSino Biologics has average predictability. Overlapping area represents the amount of predictability between CanSino Biologics time series from 11th of December 2024 to 26th of December 2024 and 26th of December 2024 to 10th of January 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of CanSino Biologics price movement. The serial correlation of 0.43 indicates that just about 43.0% of current CanSino Biologics price fluctuation can be explain by its past prices.
Correlation Coefficient0.43
Spearman Rank Test0.63
Residual Average0.0
Price Variance0.03

CanSino Biologics lagged returns against current returns

Autocorrelation, which is CanSino Biologics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting CanSino Biologics' stock expected returns. We can calculate the autocorrelation of CanSino Biologics returns to help us make a trade decision. For example, suppose you find that CanSino Biologics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

CanSino Biologics regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If CanSino Biologics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if CanSino Biologics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in CanSino Biologics stock over time.
   Current vs Lagged Prices   
       Timeline  

CanSino Biologics Lagged Returns

When evaluating CanSino Biologics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of CanSino Biologics stock have on its future price. CanSino Biologics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, CanSino Biologics autocorrelation shows the relationship between CanSino Biologics stock current value and its past values and can show if there is a momentum factor associated with investing in CanSino Biologics.
   Regressed Prices   
       Timeline  

Currently Active Assets on Macroaxis

Other Information on Investing in CanSino Stock

CanSino Biologics financial ratios help investors to determine whether CanSino Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CanSino with respect to the benefits of owning CanSino Biologics security.